Department of Psychology and the Anxiety and Illness Behaviours Laboratory, University of Regina, Regina, Saskatchewan, Canada.
Cogn Behav Ther. 2010;39(1):46-63. doi: 10.1080/16506070902980711.
This review covers the current cognitive behavioural treatments available to address fear-avoidance beliefs in patients with chronic musculoskeletal pain (CMP). Four types of treatment protocols were identified for inclusion in the review: (a) graded in vivo exposure (GivE); (b) graded activity (GA); (c) acceptance and commitment therapy (ACT); and (d) mixed cognitive behavioural protocols. Most of the research suggests that GivE and ACT result in the best outcomes for treating fear-avoidance beliefs in patients with CMP. There is also a readily apparent paucity of research from North America; indeed, most of the available studies were conducted in the Netherlands and Scandinavia. This relative absence of North American research raises potentially important questions about the role of compensation status and access to care, which differ between countries, on treatment outcome. Implications and directions for future research are discussed.
这篇综述介绍了目前可用于治疗慢性肌肉骨骼疼痛(CMP)患者的恐惧回避信念的认知行为治疗方法。为了纳入本综述,共确定了四种治疗方案:(a)分级现场暴露(GivE);(b)分级活动(GA);(c)接受和承诺疗法(ACT);和(d)混合认知行为方案。大多数研究表明,GivE 和 ACT 对治疗 CMP 患者的恐惧回避信念最有效。此外,来自北美的研究明显不足;实际上,大多数可用的研究都在荷兰和斯堪的纳维亚进行。这种相对缺乏北美的研究提出了一些潜在的重要问题,涉及补偿状况和获得治疗的机会,这些因素在不同国家存在差异,而这些差异可能会对治疗结果产生影响。本文还讨论了对未来研究的影响和方向。